Fibroblast growth factor 21 (FGF21) is a peptide hormone mainly secreted by the liver and brown adipose tissue [6], with potential clinical utility as a therapeutic approach for metabolic diseases due to its enhancement of insulin sensitivity and weight loss [7,8,9]. The gene discussed is FGF21; the disease is metabolic disease.